Nemolizumab Effective for Moderate, Severe Atopic Dermatitis Inadequately Controlled With Topical TherapyJuly 30, 2018
For patients with moderate to severe atopic dermatitis inadequately controlled with topical therapies, the anti-IL-31 receptor A humanized monoclonal antibody nemolizumab may provide benefit.
The cause of dermographic urticaria is unknown, but appears to be related to a mast cell abnormality and is probably autoimmune in nature.
Providers may have not made changes to treatment strategies due to the high effectiveness of biologics in most visits.
The dermatitis patient can be extremely complex in their presentation, as well as have multiple dermatoses complicating the diagnosis.
The combined lifetime risk for hip, forearm, and vertebral fractures that will require clinical attention is approximately 40%.
Due to a lack of pediatric dermatologists, primary-care clinicians are handling the influx of children with atopic dermatitis.
A 50% reduction in the Eczema Area and Severity Index score (EASI-50) seen in 85% of patients in the dupilumab group.
Results from four clinical trials in adults show Picato topical gel helps clear actinic keratosis on the face, scalp, trunk and extremities.
A 3-year-old boy and 45-year-old man present separately to the dermatology clinic with similar looking erythematous rashes. Can you differentiate between the two?
Two patients present with newly developed brown papules. The first patient, a 45-year-old man, presented with a new mole that continues to grow and is associated with occasional pruritus and bleeding. The second patient, a 47-year-old man, presented with a 6-month history of a brown, growing "mole." Can you differentiate between the two?
How can clinicians tell the difference between seborrheic dermatitis and scalp psoriasis?
More than half of clinician uniforms sampled from a large hospital tested positive for harmful pathogens, including MRSA.
New data indicate that combining GP100 with interleukin-2 increased clinical response, delayed recurrence and may improve survival among patients with advanced melanoma
When discussing indoor tanning with adolescent patients, appealing to their sense of vanity can go a long way toward dissuading them from engaging in risky behaviors.
Participants in a prospective cohort study who had higher serum 25-hydroxyvitamin D levels, a marker of vitamin D intake and storage, were more likely to develop squamous cell and basal cell carcinomas.
Clindamycin therapy resulted in fewer recurrences and treatment failures among children with skin and soft tissue infections vs. trimethroprim-sulfamethoxazole or beta-lactam antibiotics.
Many of the skin lesions for which primary-care providers refer patients to a dermatologist are noncancerous, but specialists often notice other lesions that are malignant.
The Infectious Diseases Society of America's first treatment guidelines on this topic focus on the management of community-acquired infections.
Time constraints, competing comorbidities, and patient embarrassment are the most frequent barriers to skin cancer screening.
What treatment and/or confirmatory testing are required before a health-care professional who has been diagnosed with MRSA infection can resume working with patients?
Are topical steroids appropriate for chronic psoriasiform dermatitis?
New data challenge earlier findings that the vaccine is less effective in people older than 75 years.
A 42-year-old man presented with abnormally thick skin of the palms.
A woman aged 34 years was referred for treatment of a recurrent, painful, nonhealing ulcer of six months' duration on her left hand.
Clinicians now have practice guidelines to follow when managing patients with MRSA infections.
A six-year-old girl has been suffering from rashes on the face, chest, and trunk that occur for a week or two, then clear only to recur the next month.
What could be causing blisters in a 52-year old patient with no other symptoms and an unremarkable health history?
Cancer metastasis when patient ignores oncology referral.
Older patients are at greatest risk for debilitating postherpetic neuralgia, but antiviral therapies ease the pain, and a new vaccine offers hope of prevention.
Two women with considerable comorbidities present with lower leg trouble.